Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice.

Por Aamdal, S., Fodstad, O., Nesland, J. M., Pihl, A.
Publicado em 1985

Prostatic carcinoma: a multivariate analysis of prognostic factors.

Por Berner, A., Harvei, S., Tretli, S., Fosså, S. D., Nesland, J. M.
Publicado em 1994

Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings

Por Risberg, B., Davidson, B., Dong, H., Nesland, J., Berner, A.
Publicado em 2000

Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas

Por Bukholm, I R K, Bukholm, G, Holm, R, Nesland, J M
Publicado em 2003

Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.

Por Berner, A., Nesland, J. M., Waehre, H., Silde, J., Fosså, S. D.
Publicado em 1993

Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX.

Por Noodt, B. B., Berg, K., Stokke, T., Peng, Q., Nesland, J. M.
Publicado em 1996

Diploid nature of hepatocellular tumours developing from transplanted preneoplastic liver cells.

Por Saeter, G., Schwarze, P. E., Nesland, J. M., Seglen, P. O.
Publicado em 1989

Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light

Por Noodt, B B, Berg, K, Stokke, T, Peng, Q, Nesland, J M
Publicado em 1999

Expression of S100A4, E-cadherin, α- and β-catenin in breast cancer biopsies

Por Pedersen, K B, Nesland, J M, Fodstad, Ø, Mælandsmo, G M
Publicado em 2002

Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence

Por Hernes, E, Fosså, S D, Berner, Aa, Otnes, B, Nesland, J M
Publicado em 2004

Uncombable hair.

Por Aguiar, A, Sobrinto-Simões, M M, Finseth, I, Johannessen, J V, Nesland, J M
Publicado em 1984

DNA ploidy in primary testicular cancer.

Por Fosså, S. D., Nesland, J. M., Pettersen, E. O., Amellem, O., Waehre, H., Heimdal, K.
Publicado em 1991

Characterization of extracellular matrix composition in breast carcinoma

Por Bergamaschi, A, Tagliabue, E, Sørlie, T, Nesland, J, Orlandi, R, Ménard, S, Børresen-Dale, A-L
Publicado no Breast Cancer Res (2005)

Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome

Por Bondi, J, Husdal, A, Bukholm, G, Nesland, J M, Bakka, A, Bukholm, I R K
Publicado em 2005

Prognostic significance of TP53 alterations in breast carcinoma.

Por Andersen, T. I., Holm, R., Nesland, J. M., Heimdal, K. R., Ottestad, L., Børresen, A. L.
Publicado em 1993

TP53 gene mutations and protein accumulation in primary vaginal carcinomas.

Por Skomedal, H., Kristensen, G., Helland, A., Nesland, J. M., Kooi, S., Børresen, A. L., Holm, R.
Publicado em 1995

Colony forming ability of human breast carcinomas: lack of prognostic significance.

Por Ottestad, L., Tveit, K. M., Hannisdal, E., Skrede, M., Nesland, J. M., Gundersen, S., Pihl, A.
Publicado em 1989

PINCH-2 expression in cancers involving serosal effusions using quantitative PCR

Por Yuan, Y., Dong, H. P., Nymoen, D. A., Nesland, J. M., Wu, C., Davidson, B.
Publicado em 2011

EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer

Por Boye, K, Nesland, J M, Sandstad, B, Haugland Haugen, M, Mælandsmo, G M, Flatmark, K
Publicado em 2012

TP53 allele loss, mutations and expression in malignant melanoma.

Por Flørenes, V. A., Oyjord, T., Holm, R., Skrede, M., Børresen, A. L., Nesland, J. M., Fodstad, O.
Publicado em 1994